Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004275449 | SCV003906490 | uncertain significance | not specified | 2023-02-22 | criteria provided, single submitter | clinical testing | The c.508G>A (p.E170K) alteration is located in exon 3 (coding exon 3) of the ANO1 gene. This alteration results from a G to A substitution at nucleotide position 508, causing the glutamic acid (E) at amino acid position 170 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
OMIM | RCV003492850 | SCV004242177 | pathogenic | Moyamoya disease 7 | 2024-01-30 | no assertion criteria provided | literature only |